Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-031082

Chief Scientific Officer sold 7,090 shares at an average $35.58 ($252,247)

  • Chief Scientific Officer acquired 7,790 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-05 Exercise or conversion : show line 1 in the form +3,895 $6.32 $24,616 73,255 D
2021-05-05 Sale : show line 2 in the form −3,195 $35.43 $113,199 69,360 D
2021-05-06 Exercise or conversion : show line 3 in the form +3,895 $6.32 $24,616 73,255 D
2021-05-06 Sale : show line 4 in the form −3,048 $35.51 $108,234 70,207 D
2021-05-06 Sale : show line 5 in the form −847 $36.38 $30,814 69,360 D
Open-market sales · 7,090 sh · avg $35.58 · $252,247

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-05-05 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −3,895 132,430 D
2021-05-06 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −3,895 128,535 D
Loading xslF345X03/doc4.xml…